[HTML][HTML] Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome

…, M Churchman, AM Meynert, T Rye, C Bartos… - Nature …, 2020 - nature.com
Endometrioid ovarian carcinoma (EnOC) demonstrates substantial clinical and molecular
heterogeneity. Here, we report whole exome sequencing of 112 EnOC cases following …

[HTML][HTML] Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high-grade serous carcinoma

RL Hollis, I Croy, M Churchman, C Bartos, T Rye… - British journal of …, 2022 - nature.com
Background Ovarian carcinosarcoma (OCS) is an uncommon, biphasic and highly aggressive
ovarian cancer type, which has received relatively little research attention. Methods We …

Structural Variants at the BRCA1/2 Loci are a Common Source of Homologous Repair Deficiency in High-grade Serous Ovarian Carcinoma

…, RL Hollis, CS Herrington, T Rye, C Bartos… - Clinical Cancer …, 2021 - AACR
Purpose: The abundance and effects of structural variation at BRCA1/2 in tumors are not well
understood. In particular, the impact of these events on homologous recombination repair …

Patterns of clinicopathological features and outcome in epithelial ovarian cancer patients: 35 years of prospectively collected data

…, K Herbert, M Churchman, C Bartos… - … Journal of Obstetrics …, 2020 - Wiley Online Library
Objective Investigate the clinical landscape of ovarian carcinoma (OC) over time. Design
Register‐based prospectively collected data. Setting South East Scotland. Sample A total of …

[HTML][HTML] A simple and robust real-time qPCR method for the detection of PIK3CA mutations

V Alvarez-Garcia, C Bartos, I Keraite, U Trivedi… - Scientific Reports, 2018 - nature.com
PIK3CA mutations are seemingly the most common driver mutations in breast cancer with
H1047R and E545K being the most common of these, accounting together for around 60% of …

[HTML][HTML] Distinct histopathological features are associated with molecular subtypes and outcome in low grade serous ovarian carcinoma

…, K van de Vijver, F Dijk, AM Meynert, C Bartos… - Scientific reports, 2023 - nature.com
Low grade serous ovarian carcinoma (LGSOC) demonstrates unique clinical and molecular
features compared to other ovarian cancer types. The relationship between common …

Multiomic characterization of high-grade serous ovarian carcinoma enables high-resolution patient stratification

…, I Croy, WG McCluggage, ARW Williams, C Bartos… - Clinical Cancer …, 2022 - AACR
Purpose: High-grade serous ovarian carcinoma (HGSOC) is the most common ovarian
cancer type; most patients experience disease recurrence that accumulates chemoresistance, …

[HTML][HTML] PIK3CA mutation enrichment and quantitation from blood and tissue

…, I Garcia-Murillas, M Beaney, NC Turner, C Bartos… - Scientific reports, 2020 - nature.com
PIK3CA is one of the two most frequently mutated genes in breast cancers, occurring in 30–40%
of cases. Four frequent ‘hotspot’ PIK3CA mutations (E542K, E545K, H1047R and …

[HTML][HTML] Clinicopathological determinants of recurrence risk and survival in mucinous ovarian carcinoma

RL Hollis, LJ Stillie, S Hopkins, C Bartos, M Churchman… - Cancers, 2021 - mdpi.com
Simple Summary Mucinous ovarian carcinoma (MOC) is a unique type of ovarian cancer.
While many MOC patients have excellent survival, patients who experience recurrence have …

Whole exome sequencing of low grade serous ovarian carcinoma identifies genomic events associated with clinical outcome

…, K van de Vijver, F Dijk, AM Meynert, C Bartos… - Gynecologic …, 2023 - Elsevier
Objectives Low-grade serous ovarian carcinoma (LGSOC) is a distinct, rare, ovarian cancer
type characterised by younger patient age and intrinsic chemoresistance. Understanding the …